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Abstract

Background: Propofol is administered as intermittent boluses to achieve deep sedation to facilitate oesophagogastroduodenoscopy. Target controlled infusion (TCI) can be employed for this purpose.
Methods: 176 adults were randomly allocated into two groups of 88 patients. Control group: Received an initial bolus of
propofol 1mg/kg, with repeat boluses of 0.25mg/kg. Intervention group: Received an initial target effect-site concentration of
4mcg/ml, followed by maintenance target effect-site concentration of 2.5mcg/ml, titrated by 0.5mcg/ml from baseline infusion
rate as needed. Oxygen saturation, blood pressure and heart rate were evaluated immediately before administering the sedative
and at 2.50, 5.00, 7.50 and 10.00 minutes. Oxygen desaturation below 90% in both study groups was recorded. Sedation starting
time, stopping time, waking up time and overall duration of time to recovery of participants in each study arm was recorded.
Results: More hypoxic episodes were observed in the intermittent bolus group with statistically significant association between
control and the incidence of hypoxia: Chi square test, p=0.037. There were more hypotensive episodes in the TCI group but
not achieving statistical significance: Chi square test for association X2(1) = 0.962, p=0.327.The time to recovery between the
two groups was comparable, with 18.84 ± 10.76 minutes in the bolus group and 19.72 ± 9.27 minutes in the TCI group; no
statistically significant difference was shown: Student’s t-test, p=0.0564.
Conclusion: TCI of propofol was associated with fewer episodes of hypoxia compared to intermittent bolus administration.
Similar hemodynamic profiles and comparable time to recovery were demonstrated by these two sedation techniques.
Keywords: Target controlled propofol infusion, intermittent boluses, oesophagogastroduodenoscopy.
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Introduction
In recent years, there has been a notable increase in the
number of patients requiring upper and lower gastrointestinal endoscopic studies as an essential part of the
diagnostic and treatment strategy for gastrointestinal
pathologies1-2. The increased training and availability of
specialists performing these procedures has contributed
to the steady rise in the numbers of endoscopy proceCorresponding author:
Vitalis Mung’ayi,
Department of Anaesthesia,
Aga Khan University, East Africa
Phone: + 254 203662175
Email: mungayi@gmail.com

dures done, as has the need for provision of procedural
sedation for this invasive procedure3. Sedation has been
shown to be essential for gastrointestinal endoscopy to
be carried out successfully4,5.
The American Society of Anesthesiologists classifies sedation as minimal, moderate and deep depending on the
patient’s responsiveness, ability to sustain an airway that
is patent, spontaneous ventilation and a reasonably sustained cardiovascular stability6.
At present, propofol is the intravenous sedative agent
possessing properties closest to that of an ideal sedative
owing to its fast onset and ultra-short duration of action;
it is no wonder then how rapidly it has gained popularity
as the preferred sedative for short procedures. Moreover,
its favorable pharmacokinetic and pharmacodynamic
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profile gives it the unique ability to provide varying levels
of sedation7. As such, propofol has secured a favorable
position in procedural sedation as has been elaborated
in guidelines published by the American Society of Anesthesiology (ASA) for the safe conduct of sedation for
various diagnostic and therapeutic procedures including
gastrointestinal endoscopy8. However, propofol is an
anaesthetic agent with a narrow therapeutic range, and
without a reversal agent. The clinical implication of this
is that propofol has a low threshold for inducing a deeper level of sedation than intended, compounded by an
increased risk of hypoventilation, apnoea or cardiovascular depression. Hence, it is largely recommended that
anaesthesiologists or nurse anaesthetists administer this
sedative agent.
For the conduct of procedural sedation, propofol may
be administered as intermittent boluses or via continuous infusion; the latter technique requiring the use of a
drug infusion pump that requires one to either manually
adjust the rate of infusion or, use a target controlled infusion system – which allows more accurate rapid titration
of the dose of this agent. A target sedation state refers
to a pharmacologically induced alteration in the level of
consciousness that allows a subject to tolerate unpleasant
procedures while aiming to maintain cardiovascular and
respiratory stability9.
The present study set out to compare the overall proportion of hypoxia between patients undergoing upper
gastrointestinal endoscopy under sedation by intermittent intravenous bolus administration of propofol – the
standard practice at the Aga Khan University Hospital
Nairobi – and target controlled infusion (TCI) of the
same sedative agent. Target controlled infusions are computerized infusion systems based on pharmacokinetics
and pharmacodynamic models specified for the individual by entering variables such as age, gender and weight10.
From these, a mathematical model can be designed and
applied in predicting the plasma concentration profile of
a given pharmacological agent after a bolus dose is given, or following an infusion of the drug. These models
are deduced from the measurement of arterial or venous
plasma concentration of the drug using standardized statistical methods and models of computer software that
are incorporated in the infusion pump11.
Numerous algorithms for targeting blood and effect site
concentration have been published and several automated
systems have been developed. Examples of TCI models
African Health Sciences Vol 19 Issue 4, December, 2019

available for the use of Propofol are Marsh and Schnider
models11.
With target-controlled infusion, a steady-state level
of propofol sedation can be attained by attempting to
achieve a user-preset target blood drug concentration12,
with a provision for rapid titration in response to varying
degrees of procedural stimulation. It therefore confers to
the user a high level of confidence regarding the predictability of depth of sedation.
In theory therefore, a more consistent level of sedation
can be achieved by this technique, minimizing the highs
and lows of plasma levels of propofol, which are experienced when, repeated boluses of are administered13. In so
doing, the degree of hypotension encountered would be
reduced, as would the intensity of respiratory depression,
which can lead to apnoea and hypoxaemia. Additionally,
TCI may also be associated with a reduce need for interventions by the person administering the sedative; thus,
effectively “frees” the anesthetist’s hand and allows for
better direct monitoring of the patient. Endoscopic sedation presents the unique challenge of “sharing the airway” with the gastroenterologist, rendering it persistently
at risk as the airway is not protected. Foremost in the prudent anesthesiologist’s safe sedation strategy is to choose
a regime that is associated with fewer incidences of respiratory depression that can lead to oxygen desaturation
and hypoxia.
The aim of this study was to compare the proportion of
hypoxia between targets controlled infusion and intermittent bolus administration of propofol in adult patients
undergoing sedation for upper gastrointestinal endoscopy. Our study question was: is there a difference in the
proportion of hypoxia between targets controlled infusion and intermittent bolus administration of propofol in
adult patients undergoing sedation for upper gastrointestinal endoscopy?
We hypothesized that there is no difference in the proportion of hypoxia between target controlled infusion
and intermittent bolus administration of propofol in
adults undergoing sedation for upper gastrointestinal endoscopy.
Methods
The study was performed following approval from the
ethical and scientific review committee at the Aga Khan
University Hospital, Nairobi. This was an open-label
randomized controlled trial. The study was carried out
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at the Aga Khan University Hospital, Nairobi, a tertiary
facility with a bed capacity of 280; a facility that is home
to a host of postgraduate medical education programs.
Figure 1: CONSORT Flow Diagram
Patients seeking care from this not-for-profit facility are

Enrollment

drawn from diverse geographical backgrounds. The patients who took part in this study were enrolled from the
preanaesthesia clinic, the inpatient wards and the endoscopy department. A participant flow diagram is shown in
figure 1.

Assessed for eligibility (n=135)

Excluded (n= 19)
♦ Not meeting inclusion criteria (n= 19 )
♦ Declined to participate (n= 0 )
♦ Other reasons (n=0 )

Randomized (n=116)

Allocated to intervention deep LMA removal
(n=58)
♦ Received allocated intervention (n=58 )
♦

Allocation
Allocated to control awake LMA removal (n=
58)
♦ Received allocated intervention (n=58 )

Did not receive allocated intervention (give
reasons) (n=0 )

♦

Did not receive allocated intervention (give
reasons) (n= 0 )

Follow-Up
Lost to follow-up (give reasons) (n= 0)

Lost to follow-up (give reasons) (n=0)

Discontinued intervention (give reasons) (n= 0)

Discontinued intervention (give reasons) (n=0)

Analysis
Analysed (n=58)
♦ Excluded from analysis (give reasons) (n=0)

Analysed (n=58)
♦ Excluded from analysis (give reasons) (n=0)

Figure 1: CONSORT Flow Diagram

The target population included all adults scheduled for 5. History of chronic exposure to sedative medication.
non-emergent diagnostic Enrollment
or therapeutic upper gastroinAssessed for eligibility (n=135)
testinal endoscopy i.e. oesophagogastroduodenoscopy The present study applied a margin of 0.12; a difference
(OGD) under sedation. The sample population included of 8% was considered
to be significant should there be
Excluded (n= 19)
♦ Not meeting inclusion criteria (n= 19 )
ASA I and II adults between the ages of 18 - 65 years a difference in♦ the
proportion of hypoxia observed beDeclined to participate (n= 0 )
Other reasons
(n=0 )
who were to undergo non-emergent upper gastrointesti- tween the two♦ modes
of administering
propofol during
nal endoscopy at the Aga Khan University between Jan- the conduct of OGD. The sample size for the study was
(n=116)using the non-inferiority formula. This samuary 2017 and March 2017 under sedation. Reasons for Randomized
determined
exclusion from the study were:
ple was sufficient for the test of non-inferiority or equiva1. Known allergy to propofol, midazolam, soybean, egg. lence between target controlled infusion and intermittent
Allocation
2. Active respiratory infection.
bolus administration of propofol in the proportion of
Allocated to intervention deep LMA removal
Allocated to control awake LMA removal (n=
3. History or indicator
of large airway compromise e.g. patients that58)develop hypoxia. In applying the above for(n=58)
♦ Received allocated intervention (n=58 )
♦ Received
allocated intervention
(n=58 )
obstructive sleep apnoea,
chronic obstructive pulmonary mula, with the
assumption
of a significance
level of 5%,
♦ Did not receive allocated intervention (give
♦ Did not receive allocated intervention (give
disease, presence of stridor,
or (n=0
known
history of difficult and a power ofreasons)
80%,(n=
a sample
size of 80 patients per arm
reasons)
)
0)
bag-valve-mask ventilation.
was deemed adequate to demonstrate an 8% difference in
4. Patients requiring additional types of sedative agents to Follow-Up
the proportion of hypoxia between patients in these two
Lost to follow-up (give reasons) (n= 0)
Lost accounting
to follow-up (givefor
reasons)
(n=0)
achieve optimal sedation.
groups. Upon
up to
a 10% drop-out rate,
Discontinued intervention (give reasons) (n= 0)
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Discontinued intervention (give reasons) (n=0)
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Analysis
Analysed (n=58)
♦ Excluded from analysis (give reasons) (n=0)

Analysed (n=58)
♦ Excluded from analysis (give reasons) (n=0)

a total sample size of 176 (88 in each arm) was arrived at.
Patients scheduled for gastrointestinal endoscopy were
screened and assessed for eligibility during the pre-anaesthesia assessment visit in the anaesthesia clinic, in-patient
ward reviews and the endoscopy department. The use of
consecutive sampling was applied, meaning: there was opportunity to recruite every subject who was found to be
eligible to participate in this study. An informed consent
was obtained from the patient by the primary investigator
after an elaborate description of the purpose and nature
of the study had been provided. Ample time was also
allocated to satisfactorily address any questions that they
may have had. Participants from whom informed consent
had been obtained were assigned randomly to either arm.
A total of 88 yellow cards and 88 blue cards were put
in brown (opaque) envelopes and sealed at the start of
the study. These envelopes were then mixed well together; each colored card representing one arm of the study.
Yellow cards represented the intervention arm (target
controlled infusion) and the blue cards represented the
control arm (intermittent bolus). Once the participants
provided consent to participate in the study, they were required to take any envelop and open it to display the card
it contained. The revealed card was then placed in the
participant’s file for ease of identification of the group
they had been randomized into and to guide the administration of the appropriate mode of intravenous propofol
for sedation as described for the respective arms.
Upon arrival at the endoscopy suite, the anaesthetist administering sedation opened the patient’s file and saw
from the colour of the card contained therein which arm
the patient had been randomized into. Standard monitoring was commenced: electrocardiography, automated
non-invasive blood pressure measurement and pulse oximetry. Supplemental oxygen via nasal prongs at 3 liters
per minute was given to all patients in both study arms
at least 3 minutes before commencing sedation. Intravenous midazolam 0.05mg/kg was administered to subjects
in both study arms. In the intermittent bolus group: An
initial bolus propofol 1mg/kg, followed by repeat boluses
of 0.25mg/kg as needed was given till the end of the procedure. In the target controlled infusion group: Effector
targeted Schneider model was used via target controlled
infusion pump model, Injectomat TIVA agilioTM. Initial
target effect-site concentration of 4mcg/ml for propofol was given until loss of consciousness was achieved.
This was immediately followed by a target effect-site concentration infusion of 2.5mcg/ml, titrated by 0.5mcg/
African Health Sciences Vol 19 Issue 4, December, 2019

ml upward or downward as needed till the end of the
procedure. A Ramsay sedation score of <5 was used as
criteria for additional dosing14. We opted to use the Ramsay Sedation Scale because it is the scoring system most
commonly referred to at our facility.
Patients were monitored continuously; non-invasive
blood pressure measurements were time-cycled to take
automated readings at 2.5-minute intervals. The heart
rate, respiratory rate and oxygen saturation was depicted
by continuous respective waveforms and corresponding
numerical values on the monitor screen throughout the
procedure.
Upper gastrointestinal endoscopy was started by gastroenterologist only after patient entered deep sedation. Any
episode of oxygen desaturation below 90% was documented; airway maneuvers such as chin-lift and jaw-thrust
were applied promptly to re-establish patency of airway.
If the patient became apnoeic, the endoscopy procedure
was to be interrupted and mask ventilation with highflow 100% oxygen was to be administered until there was
resumption of spontaneous ventilation. The end of the
endoscopy sedation procedure was marked by withdrawal
of the endoscope from the mouth. The patient was then
transferred to the post-sedation recovery room for continuous monitoring till point of being discharged from
the endoscopy suite to go home or to the ward. The time
to recovery from sedation was recorded for each patient
in both study arms i.e. duration of time from the end of
the endoscopy procedure signaled by withdrawal of the
scope from the oral cavity and cessation of administration of the sedative, to the time to respond to a verbal
command. This was assessed at 5-minute intervals. The
verbal command was given by the recovery room nurse
who stood by the patient’s bed on the side he or she was
facing, and called them by their name no more than twice
at a time, in a normal/conversational tone. The patient
was neither touched nor subjected to any other form
of stimulation in an attempt to determine their level of
wakefulness. This routine was also well described to the
recovery room nurses as well as practically demonstrated
to them how to correctly make this assessment. In addition, I frequently went to the recovery room to ensure
this was uniformly adhered to.
Data was checked for accuracy and completeness, then
entered and analyzed by use of SPSS (Version 21.0, Chicago-Illinois). Continuous data was analyzed and summa3139

rized as means and standard deviation while the categorical data was analyzed and displayed by use of frequencies
and proportions. The proportion of patients with hypoxia (primary outcome) between the TCI and intermittent
bolus groups was compared with the use of Chi-square
test. The secondary outcome (hypotension and time to
recovery in minutes) was compared with the use of independent sample t-tests. Where applicable, P-values and
95% confidence intervals (CIs) were also to be calculated.
A P value <0.05 was considered statistically significant,
based on two-sided tests.

Results
The age, sex, weight, and height were not significantly
different (p=0.502; p=0.546; p=0.388; p=0.054) in both
groups as shown in table 1. The TCI group had a systolic
blood pressure of 120.25 ± 18.87, while that of the Bolus
group was 123.73 ± 19.13; a difference of 3.48mmHg that
was not statistically significant (95% CI, -2.18 to 9.13), t
(174) = 1.214, p = 0.226. However the bolus group had a
baseline diastolic blood pressure of 75.84 ± 14.73, while
that of the TCI group was 72.45 ± 10.63; a difference
of 3.39mmHg which also was not statistically significant
(95% CI, -0.44 to 7.21), t (174) = 1.749, p =0 .082.

Table 1: Comparison of Baseline Characteristics between Bolus and TCI Groups
Frequency n (%)
BOLUS
Mean(±SD)
38.6(13.2)

TCI
Mean(±SD)
39.0(11.3)

Male
Female
ASA classification
I
II

39 (44.3)
49 (55.7)

43 (48.9)
45 (51.5)

0.546

53 (60.2)
35 (39.8)

66 (75.0)
22 (25.0)

0.036

Mean Weight
Mean Height

71.3( 12.3)
167.4(7.1)

74.1(14.62)
169.3(6.57)

0.388
0.054

Age
Sex

Mean BMI

25.5 (3.7)
Mean Initial blood pressure Mean ± SD
(mmHg)
Bolus
Systolic
123.7 (19.1)
Diastolic
75.8 (14.7)
83.2 (13.9)
Mean HR
95.57 (1.7)
Mean SpO2

25.6 (4.29)

p-value
0.502

0.655

TCI
120.3 (18.9)
72.5 (10.6)
85.2 (13.4)

0.226
0.082
0.338

96.8 (1.8)

0.304

The bolus group had more cases of hypoxia (n = 28) than The bolus and TCI groups were assessed for occurrence
the TCI group (n = 16).This was statistically significant, p of hypotension. As earlier defined in this study, hypo= 0.037 (95% CI, 1.039 to 4.243).This is shown in table 2. tension was described as a 20% decrease in the baseline
systolic blood pressure.

3140

African Health Sciences Vol 19 Issue 4, December, 2019

Table 2: Proportion of Hypoxia between Bolus and TCI Groups
Group
Bolus
TCI

Frequency n (%)
Yes
No
28 (31.8)
60 (68.2)
16 (18.2)
72 (81.8)

p-value
0.037

An independent-samples t-test applied to determine if there
were differences in the initial systolic blood pressure in patients
receiving Bolus and TCI for sedation.

It was found that of those in the TCI group, 30 (34.1%) of the Bolus group. This finding was not statistically sighad experienced hypotension compared to 24 (27.3%) nificant, p=0.327 (95% CI, .381 to 1.380).This shown in
table 3.

Table 3: Proportion of Hypotension between Bolus and TCI Groups
Group

Frequency n (%)

Bolus
TCI

Yes

No

24 (27.3)
30 (34.1)

64 (72.7)
58 (65.9)

p-value

0.327

The Bolus arm had a mean heart rate of 83.17± 13.94 2.06 (95% CI, -6.04 to 2.08), t (174) = 1.214, p = 0.338.
compared to the TCI arm (85.15± 13.35), a difference of This is shown in table 4.

Table 4: Comparison of Heart Rate between Bolus and TCI Group
Heart rate (Mean ± SD) - Initial

Bolus
83.17± 13.94

TCI
85.15± 13.35

p-value
0.338

An independent-samples t-test carried out to determine if there were differences in the heart rate in patients receiving
Bolus and TCI for sedation.

It was found that participants in the Bolus group had was the duration of sedation not statistically different,
a comparable duration of sedation to those in the TCI but the difference was also clinically insignificant. (95%
group (6 ± 3 and 6 ± 1 minute, respectively). Not only CI, -0:00 to 0:01), t (174) = 1.214, p = 0.519. This shown
in table 5.

Table 5: Comparison of Duration of Sedation between bolus and TCI groups

Duration of Sedation (in minutes)

Mean ± SD
Bolus
6±3

TCI
6±1

p-value
0.519

An independent-samples t-test run to determine if there were differences in the duration of sedation in patients receiving
Propofol boluses versus TCI during sedation.
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The Bolus group had a shorter recovery time (18.84 ±
10.77) compared to the TCI group (19.72 ± 9.28); a difference that was not statistically significant (95% CI, -2.12
to 3.87), t (174) = 0.578, p = 0.564. This is shown in table
6. No statistically significant association between inter-

vention and duration taken to wake up was demonstrated,
χ26) = 8.592, p = 0.198.This is shown in table 7. Of the
patients who took longer than 30 minutes to wake up in
either group, the majority of them woke up between 31
and 40 minutes. The longest time asleep in the TCI group
was 42 minutes, and 48 minutes in the Bolus group.

Table 6: Comparison of Recovery Time between Bolus and TCI Groups
Recovery time in min (Mean ± SD)
Range (min)

Bolus
18.84±10.77
5 - 66

TCI
19.72±9.28
3 - 42

p-value
0.564

An independent-samples t-test run to determine if there were differences in the recovery times in patients receiving Bolus and
TCI for sedation.

Table 7: Distribution of Patients by Duration Taken to Wake Up
Duration (minutes)
≤5
6 – 10
11 – 15
16 – 20
21 – 25
26 – 30
>30
Total

AC

Frequency n (%)
Bolus
TCI
2 (2.3)
5 (5.7)
18 (20.5)
6 (6.8)
24 (27.3)
25 (28.4)
13 (14.8)
14 (15.9)
13 (14.8)
13 (14.8)
7 (8.0)
11 (12.5)
11 (12.5)
14 (15.9)
88 (100.0)
88 (100.0)

Discussion
The conduct of gastrointestinal endoscopy has in recent
years seen an appreciable rise in the numbers of diagnostic and therapeutic procedures being carried out. This is
perhaps driven by an increasing awareness by the lay public of the benefits of undergoing this investigation given the apparent rise in the incidence of gastrointestinal
pathologies – including cancers, alongside the increasing
training opportunities and growing availability of gastroendoscopy specialists. With this comes the inevitable
need to avail procedural sedation to facilitate the conduct
of these invasive investigations. Manual intermittent bolus administration of propofol has been the main-stay
mode of providing a Propofol-based sedation regimen.
However, in the recent years, target controlled infusion
of propofol for procedural sedation has steadily gained
popularity.
The present study set out to investigate and compare
the proportion of hypoxia between adults receiving intermittent boluses of propofol versus target controlled
3142

p-value
0.198

infusion of propofol for sedation during upper gastrointestinal endoscopy. In addition, the study was also guided by the following secondary objectives: to compare the
proportion of hypotension and bradycardia between the
two study arms, as well as the time to recovery between
the two groups.
The key finding was that the occurrence of hypoxia was
proportionally higher in the intermittent bolus group
(31%) compared to that in the TCI group (18%) - a finding that was deemed statistically significant p = 0.037. YiTing Chang et al found a similar observation in a study
involving 100 subjects, where he explored the quality and
plausibility of propofol TCI as a sedation method for endoscopy15. Although it was reported that there was no
statistically significant difference in the overall respiratory
effects observed between the two arms, the actual number of patients who experienced oxygen desaturation requiring intervention was higher in the control group. In
both instances, respiratory depression and hypoxia was
observed soon after administering the induction dose of
African Health Sciences Vol 19 Issue 4, December, 2019

propofol. This may be attributed to the sudden surge in
the plasma and target site concentration of propofol that
is characteristic of bolus administration of a relatively
large dose of the drug within a short period. While this
may well confer the advantage of rapid loss of consciousness and achievement of the desired depth of sedation,
the respiratory-depressant effect of propofol is accentuated leading to bradypnoea, hypopnea or apnoea, and oxygen desaturation. In a study similar to the present one,
Arif H M Marsaban et al compared sedation outcomes
between these two sedation techniques, including the total consumption of propofol, side effects and recovery
time4. Here too, the incidence of desaturation was found
to be proportionally larger in the bolus group (12%) than
in the intervention group (4%). However, the variable
power of the study was very low and so the accuracy of
the conclusions of this particular study could not be ascertained.
Concerning haemodynamic parameters, the proportion
of hypotension was found to be proportionally higher in
the intervention group, with 34% of subjects in the TCI
arm recording systolic blood pressures below 20% of
the baseline value, compared to 27% in the bolus group.
However, a statistically significant association between
intervention and hypotension was not demonstrated.
In a clinical trial involving 100 participants undergoing
OGD and 120 scheduled for colonoscopy Chan WH et
al12 found that, of the subjects undergoing OGD, significantly lower trough systolic blood pressures were documented in the control group (105 +/- 19mmHg) versus TCI group (113 +/- 20mmHg) p=0.043. However,
this study did not report analysis of the variation of the
systolic blood pressure from the baseline. This may have
been significant. Important to note, too, is that the participants in that study had been randomly enrolled to receive
TCI with propofol or intermittent boluses of a cocktail
regimen containing propofol, midazolam and alfentanil.
The latter two drugs (a benzodiazepine and an opioid)
are pharmacological agents with cardiovascular depressant effects in their own right; the drop in blood pressure
that was experienced by these patients was probably because of the combination of the peripheral vasodilalatory
effect of propofol and the direct cardio-depressant effects of alfentanil. Repeated bolus administration of this
sedative cocktail would likely – and predictably – render
a cumulative cardiovascular depressant effect, leading to
higher rate of hypotension in the patients receiving boluses of the cocktail regimen than those in the TCI group
who received an infusion of propofol alone. This may
African Health Sciences Vol 19 Issue 4, December, 2019

have influenced the findings of the study in this regard.
By not including the use of an opioid agent in only one
arm of the sedation protocol, the present study obviated
the confounding influence of an opioid on the overall
haemodynamic profile of the patients, thereby arriving at
a more accurate conclusion of the effect of either sedation techniques on the haemodynamic parameters of the
patients.
It is prudent now to acknowledge that, in the current
study as well as in the referenced trials, the pre-procedure fluid status of the participants was not known; we
therefore cannot rule out the possibility of some of them
being relatively fluid-depleted at the start of administration of the sedation regien. As such, the association of
either mode of propofol administration (TCI or intermittent boluses) to the occurrence of hypotension may have
been exaggerated.
In the present study, one patient experienced a transient,
self-limiting episode of bradycardia (defined by a heart
rate below 50 beats per minute) whose lowest heart rate
recorded was 47 beats per minute. This subject was in the
bolus group; of note is that this participant had a relatively
low initial heart rate of 61 beats per minute (compared to
the mean baseline heart rates of 83.17 ± 13.94 and 85.15
± 13.35 – in the control and TCI groups, respectively)
that may have predisposed the patient to developing an
even slower heart rate soon after receiving the induction
dose of Propofol. This event was not clinically significant as it lasted less than 30 seconds, with resumption of
normal heart rate without requiring any pharmacological
intervention to treat it. The patient’s blood pressure was
not adversely affected and remained stable throughout
the rest of the course of the procedure.
Upon analysis of the recovery time between the two
groups, it was noted that of those who responded to a
verbal command within 5 minutes of cessation of the
sedation regimen, most had been recipients of a target
controlled infusion of Propofol; perhaps a representation of the patients whose procedure time was relatively
shorter than the rest and therefore had an overall lower
consumption of Propofol, predictably leading to a faster
recovery time. With the exception of the cluster of patients in the Bolus group who woke up 6 – 10 minutes
that formed the majority in that time cluster, the overall
time to recovery between the two propofol sedation techniques was largely found to be comparable; with no significant difference demonstrated in the bolus (M=18.84,
SD=10.767) and TCI (M=19.72, SD=9.276) arms, t (174)
3143

= .578, p=.564, suggesting that the time to recovery was
not affected by the method used for sedation.
In revisiting the study protocol, specific interventions
were to be administered promptly in case any serious respiratory or cardiovascular complications occurred. With
the exception of one patient in the TCI group who developed moderately severe laryngospasms at the end of the
procedure, no other serious complication was observed
in any of the other study participants. A single or combination of factors may trigger laryngospasm in a patient
undergoing an invasive diagnostic or therapeutic intervention. In an analysis of incidences reported to the Australian Incident Monitoring Study (AIMS) that involved
voluntary reporting of any unintended incident that occurred in the course of care of a patient, of the first 4000
reports, 189 were cases of laryngospasm. Amongst the
precipitating factors attributed are airway manipulation
(44%), blood/secretions in the pharynx (12%), regurgitation/vomiting (9%), surgical stimulus (5%), moving
patient (4%), irritant volatile agent (2%) and failure of
anaesthetic delivery system (2%). In 22% of patients who
experienced laryngospasm no clear cause could be identified16. Propofol in itself has a suppressive effect on the
airway reflexes; compared to volatile anesthetic, the use
of propofol sedation/anesthesia is associated with reduced airway hyperreactivity12, and is in fact the agent of
choice in the management of laryngospasm by increasing
the depth of anaesthesia, with or without paralysis with
succinylcholine18. It is therefore improbable that target
controlled infusion of this agent was a precipitating factor of laryngospasms in that single subject in the TCI
group. Instead, it more likely would have been attributed
to the production of excessive airway secretions during
the conduct of OGD, an observation that was peculiar
to this patient, and perhaps the stimulation of the oropharynx with the endoscope in a moment of a lighter
plane of sedation than was intended. This complication
was expeditiously managed by oropharyngeal suctioning of secretions and administering continuous positive
pressure ventilation of 100% Oxygen via a Mapleson A
circuit, with resolution of the airway spasms soon after.
The patient went on to recover from sedation without
any further untoward events.
By demonstrating a lower proportion of hypoxia with
the use of target controlled infusion compared to intermittent bolus administration of Propofol, the results of
this study therefore rejects the null hypothesis: there is no
difference in the proportion of hypoxia between targets
controlled infusion of propofol and intermittent bolus
3144

administration in adults undergoing sedation for upper
gastrointestinal endoscopy.
Strengths
This study is the first of its kind to be conducted in a
tertiary facility in this region of the globe.
Limitations
As this was a single-centre trial conducted at a tertiary facility, the results obtained in this study may not be
generalizable across different clinical set-ups and patient
populations. Secondly, neither the anaesthesiologist nor
the endoscopist was blinded in this study, resulting in a
Hawthorne effect, which may have invariably influenced
the sedation outcomes under study. However, the nature of the study in itself rendered blinding of the anaesthesiologist and endoscopist impossible. Thirdly, the
induction and maintenance doses of Propofol in either
arm of the study were empirically determined; at best,
these were closely related to the doses used in comparable
studies12,16,17. Even then, for both propofol sedation techniques the sedative was given by titrating it to effect, with
the goal of achieving a Ramsay score of 5.
Conclusion
In conclusion, based on the findings of this study, target controlled infusion of propofol at a targeted effector site concentration of 2.5mcg/ml is associated with a
lower proportion of hypoxia compared to intermittent
bolus administration of Propofol at 0.25mg/kg given as
required. In this regard, TCI mode of propofol sedation
has been demonstrated to provide a safer alternative to
the traditional manual intermittent bolus administration
of the same sedative agent. The single episode of laryngospasms observed in one patient in the TCI group may
have been attributed to the presence of copious airway
secretions rather than the mode of propofol sedation given. Additionally, the results of this study suggest that the
haemodynamic profile as well as the time to recovery is
not influenced by the choice of propofol sedation technique used.
Trial registration PACTR201708002325400
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